Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Treasury Shares (2021 - 2025)

Roivant Sciences' Treasury Shares history spans 5 years, with the latest figure at $20.3 million for Q2 2025.

  • For Q2 2025, Treasury Shares fell 71.55% year-over-year to $20.3 million; the TTM value through Jun 2025 reached $20.3 million, down 71.55%, while the annual FY2025 figure was $348527.0, 96.93% down from the prior year.
  • Treasury Shares reached $20.3 million in Q2 2025 per ROIV's latest filing, down from $57.1 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $71.3 million in Q2 2024 to a low of $2.1 million in Q4 2023.
  • Average Treasury Shares over 5 years is $23.4 million, with a median of $20.5 million recorded in 2023.
  • Peak YoY movement for Treasury Shares: plummeted 84.02% in 2022, then soared 2307.53% in 2024.
  • A 5-year view of Treasury Shares shows it stood at $22.6 million in 2021, then tumbled by 84.02% to $3.6 million in 2022, then tumbled by 40.75% to $2.1 million in 2023, then skyrocketed by 2307.53% to $51.5 million in 2024, then crashed by 60.63% to $20.3 million in 2025.
  • Per Business Quant, the three most recent readings for ROIV's Treasury Shares are $20.3 million (Q2 2025), $57.1 million (Q1 2025), and $51.5 million (Q4 2024).